Literature DB >> 30047194

Head and neck squamous cell carcinoma drives long interspersed element-1 hypomethylation in the peripheral blood mononuclear cells.

Areeya Arayataweegool1, Ratakorn Srisuttee2, Patnarin Mahattanasakul3,4, Napadon Tangjaturonsasme3, Virachai Kerekhanjanarong3, Nakarin Kitkumthorn5, Apiwat Mutirangura6.   

Abstract

OBJECTIVE: Alteration of long interspersed element-1 (LINE-1) methylation in peripheral blood mononuclear cells (PBMCs) has been simultaneously activated to breast carcinogenesis due to its secretion. To evaluate the effect in head and neck squamous cell carcinoma (HNSCC), LINE-1 methylation levels and patterns have been measured both in vitro and in vivo.
METHODS: Analysis of LINE-1 methylation in cocultured models between HNSCC cell lines and normal PBMCs was performed. The observation of PBMCs of HNSCC patients compared to PBMCs of normal controls was performed using the semiquantitative combined bisulfite restriction analysis technique.
RESULTS: Downregulation of LINE-1 methylation was significantly found in the PBMCs cocultured with all HNSCC cell lines compared to normal PBMCs. Likewise, a reduction in LINE-1 methylation levels was observed in PBMCs of HNSCC compared to normal PBMCs (p < 0.0001). Receiver operating characteristic analysis demonstrated the potential of the unmethylated alleles (u Cu C) of LINE-1 for distinguishing the PBMCs of HNSCC patients from normal controls with 100% sensitivity and specificity.
CONCLUSION: Our data supported that the alteration of LINE-1 methylation levels in PBMCs was influenced by HNSCC secretions. Moreover, the unmethylated LINE-1 allele of PBMCs was proved to be an effective tumor marker and possesses a potential as HNSCC diagnostic tool.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  coculture technique; head and neck squamous cell carcinoma; long interspersed element-1; methylation; peripheral blood mononuclear cells

Year:  2018        PMID: 30047194     DOI: 10.1111/odi.12944

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  2 in total

Review 1.  Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics.

Authors:  Ana Capote-Moreno; Eva Ramos; Javier Egea; Francisco López-Muñoz; Emilio Gil-Martín; Alejandro Romero
Journal:  Cancers (Basel)       Date:  2019-11-02       Impact factor: 6.639

2.  Quantitative STAU2 measurement in lymphocytes for breast cancer risk assessment.

Authors:  Charoenchai Puttipanyalears; Sikrit Denariyakoon; Phonthep Angsuwatcharakon; Vitavat Aksornkitti; Mawin Vongsaisuwan; Sutasinee Asayut; Somchai Thanasitthichai; Narisorn Kongruttanachok; Chatchawit Aporntewan; Apiwat Mutirangura
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.